Abstract:Individualized treatment rules can improve health outcomes by recognizing that patients may respond differently to treatment and assigning therapy with the most desirable predicted outcome for each individual. Flexible and efficient prediction models are desired as a basis for such individualized treatment rules to handle potentially complex interactions between patient factors and treatment. Modern Bayesian semiparametric and nonparametric regression models provide an attractive avenue in this regard as these allow natural posterior uncertainty quantification of patient specific treatment decisions as well as the population wide value of the prediction-based individualized treatment rule. In addition, via the use of such models, inference is also available for the value of the optimal individualized treatment rules. We propose such an approach and implement it using Bayesian Additive Regression Trees as this model has been shown to perform well in fitting nonparametric regression functions to continuous and binary responses, even with many covariates. It is also computationally efficient for use in practice. With Bayesian Additive Regression Trees, we investigate a treatment strategy which utilizes individualized predictions of patient outcomes from Bayesian Additive Regression Trees models. Posterior distributions of patient outcomes under each treatment are used to assign the treatment that maximizes the expected posterior utility. We also describe how to approximate such a treatment policy with a clinically interpretable individualized treatment rule, and quantify its expected outcome. The proposed method performs very well in extensive simulation studies in comparison with several existing methods. We illustrate the usage of the proposed method to identify an individualized choice of conditioning regimen for patients undergoing hematopoietic cell transplantation and quantify the value of this method of choice in relation to the optimal individualized treatment rule as well as non-individualized treatment strategies.

Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree.

Bayesian Additive Decision Trees of Biomarker by Treatment Interactions for Predictive Biomarker Detection and Subgroup Identification

Subgroup identification in clinical trials: an overview of available methods and their implementations with R

A Modified Classification Tree Method for Personalized Medicine Decisions.

Patient stratification in multi-arm trials: a two-stage procedure with Bayesian profile regression

A Bayesian approach to subgroup identification.

Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees

Subgroup Analysis from Bayesian Perspectives

Probabilistic learning of treatment trees in cancer

Optimal Bayesian Hierarchical Model to Accelerate the Development of Tissue-Agnostic Drugs and Basket Trials.

Tree-Based Analysis

BLAST: Bayesian Latent Subgroup Design for Basket Trials Accounting for Patient Heterogeneity

Bayesian Group Sequential Enrichment Designs Based on Adaptive Regression of Response and Survival Time on Baseline Biomarkers.

A Bayesian Classification Trees Approach to Treatment Effect Variation with Noncompliance

Subgroup Identification using Covariate Adjusted Interaction Trees

Estimation of Causal Effects of Multiple Treatments in Observational Studies with a Binary Outcome

Incorporating External Data into the Analysis of Clinical Trials via Bayesian Additive Regression Trees

A Bayesian multivariate hierarchical model for developing a treatment benefit index using mixed types of outcomes

ASSESSING THE HETEROGENEITY OF TREATMENT EFFECTS BY IDENTIFYING THE TREATMENT BENEFIT RATE AND TREATMENT HARM RATE

Unmasking Bias: A Framework for Evaluating Treatment Benefit Predictors Using Observational Studies

An Interpretable Framework to Identify Responsive Subgroups from Clinical Trials Regarding Treatment Effects: Application to Treatment of Intracerebral Hemorrhage